Full-Time
Venture capital firm for early-stage startups
$65k - $90k/yr
Senior
Remote in USA
The role supports one or more partner practices nationally and will assist with expanding state licensures as needed.
Menlo Ventures invests in early-stage startups, focusing on sectors like artificial intelligence, healthcare, financial technology, and software as a service (SaaS). The firm collaborates with founders to help them identify product-market fit, create effective go-to-market strategies, and grow their businesses. Menlo Ventures primarily targets innovative startups with significant growth potential in the technology and healthcare industries. Their business model involves providing capital and strategic guidance in exchange for equity stakes in these companies. As the startups succeed and either get acquired or go public, Menlo Ventures profits from the increase in value of its equity holdings. The firm has a history of successful investments, contributing to its reputation in the venture capital space.
Company Size
51-200
Company Stage
N/A
Total Funding
$24.9B
Headquarters
Menlo Park, California
Founded
1976
Help us improve and share your feedback! Did you find this helpful?
Health Insurance
Dental Insurance
Vision Insurance
Unlimited Paid Time Off
Company Equity
/PRNewswire/ -- Today, Goodfire, the leading AI interpretability research company, announced a $50 million Series A funding round led by Menlo Ventures with...
What You Should Know: – Brellium, the AI-powered clinical and payor compliance platform helping healthcare organizations streamline chart audits and reduce clinical risk, has secured $16.7M in Series A funding led by First Round Capital, Left Lane Capital, and Menlo Ventures, with participation from Digital Health Venture Partners and Necessary Ventures. – The funding will fuel team growth, product development, and broader adoption across healthcare segments like mental health, weight loss, autism, and hospice care.Accurate and thorough documentation is essential in healthcare. It ensures that providers are reimbursed for their services and that patients receive appropriate care. However, inadequate documentation can have severe repercussions for provider groups, including prepayment reviews, insurance clawbacks (which can destabilize finances), misdiagnoses, inadequate treatment, and poor patient outcomes. The co-founder of Brellium experienced a personal medical misdiagnosis that led to two years of frustration, characterized by numerous specialist visits, ineffective treatments, and administrative burdens like insurance phone tag and billing issues. This experience revealed a critical flaw in the healthcare system: documentation oversights can trigger a cascade of negative consequences, impacting both patients and providers. Brellium was founded to address this systemic failure by providing providers with tools to deliver measurement-based, clinically accurate, and compliant care, ultimately leading to better and faster patient recovery.Brellium’s AI-Powered Solution: Proactive and Comprehensive ComplianceBrellium offers an AI-powered clinical compliance platform designed to ensure that every patient visit meets payor and clinical quality standards while minimizing the manual workload for clinical teams. Unlike reactive spot-checks, Brellium proactively audits every patient visit, identifying potential compliance risks before they escalate into problems
Good Job Games secured $23M seed round from Menlo Ventures and Tripledot co-founder Akin Babayigit’s Arcadia to build a legacy entertainment company.
Aurascape has emerged from stealth with $50 million in funding, led by Mayfield Fund and Menlo Ventures, and supported by investors like former CEOs of Palo Alto Networks and Symantec. The company launched its AI Activity Control platform, addressing the need for AI-native security solutions as AI adoption grows. CEO Moinul Khan emphasized the importance of re-imagining security for AI, given traditional offerings' limitations in handling AI applications.
REDWOOD CITY — Solace, a digital health platform that connects patients with expert health advocates, has closed a $60 million Series B funding round.